| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-06 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.14 | 9e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0004 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |